NASDAQ FIRST NORTH GROWTH MARKET,
TICKER: STENO
- Owning TO2 Warrants is a requirement for subscribing to the new
Stenocare shares with a discount of 30%. -
Shareholders that subscribed for the Stenocare UNIT Right Issue during May/
June 2023 also received TO2 Warrants that can now be exercised (used) or sold to the market. - Becoming an owner of TO2 Warrants: TO2 Warrants are being traded daily and can be purchased or sold under ticker "STENO TO 2" or using the ISIN code DK0062493615.
-
Each TO2 Warrant owned, entitles the owner subscribe (buy) one new
Stenocare share with a discount of 30%. -
The discount arises as the subscription price for the new shares is calculated as subtracting a 30% discount of the 10-day volume weighted average price of the
Stenocare mother share as traded on Nasdaq First North Growth Market Denmark in the periodMay 27 to June 7 . The price will be announced onJune 7, 2024 (after 17:00 Central European Time). -
TO2 Warrants that are NOT sold or used to subscribe for new shares with a discount before
June 21 (time17:00 CET ) will become void.
- Use all the TO2 Warrants to subscribe for new
Stenocare shares at a 30% discount duringJune 10-21 . -
Use all the TO2 Warrants and purchase additional TO2 Warrants to subscribe for more
Stenocare shares at a discount. -
Use only part of the TO2 Warrants for new
Stenocare shares at a discount and sell the remaining TO2 Warrants beforeJune 19, 2024 . -
Decide not to use the TO2 Warrants and sell all TO2 Warrants before
June 19, 2024 .
Information about the upcoming TO2 Warrant is available on the investor homepage: https://stenocare.com/to2-warrant-introduction/
Sign-up for
For additional information regarding
About
www.stenocare.com www.stenocare.dk
https://news.cision.com/stenocare/r/stenocare-is-sharing-early-information-about-the-upcoming-share-issue--to2-warrant--transaction-in-j,c3985996
https://mb.cision.com/Main/17551/3985996/2814010.pdf
(c) 2024 Cision. All rights reserved., source